Status:

NOT_YET_RECRUITING

Biodegradable Magnesium Bone Plate and Screw Fixation in Jaw Surgery

Lead Sponsor:

The University of Hong Kong

Conditions:

Orthognathic Surgical Procedures

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of using high-purity magnesium bone plates and screws for internal fixation in jaw surgery. The investigators aim to assess whether the...

Detailed Description

Bone plate and screw fixation is a well-recognized system for internal fixation in jaw surgery, encompassing fracture fixation, orthognathic surgery, and craniofacial reconstruction. Along the develop...

Eligibility Criteria

Inclusion

  • Participants must be 18 years of age or older.
  • Participants must have confirmed indications for jaw surgery with internal fixation, such as alveolar onlay bone grafting, fracture fixation, orthognathic surgery, or reconstructive surgery.
  • Participants should have adequate bone quality and sufficient bone volume to support the placement of magnesium bone plates and screws.
  • Participants must provide written informed consent, indicating their understanding of the potential risks and benefits of magnesium bone plate and screw fixation.

Exclusion

  • Participants with certain medical conditions that may affect bone healing or increase the risk of complications, such as uncontrolled diabetes, severe osteoporosis, multiple myelomas, or active bone infections.
  • Participants with medical conditions that may exacerbate or predispose them to systemic side effects of magnesium implants, thus contraindicating their use, should be excluded. These conditions include chronic kidney disease, hypermagnesemia, severe electrolyte imbalances, severe heart disease (especially in those with a history of arrhythmias or heart failure), myasthenia gravis, abnormal thyroid functions, hyperparathyroidism, and adrenocortical insufficiency.
  • Participants with known allergies or hypersensitivity to magnesium.
  • Participants with an ASA score of 3 or above, indicating a higher risk for general anesthesia.
  • Participants who are pregnant or breastfeeding.
  • Participants deemed unlikely to comply with the study protocol, such as attending follow-up appointments or adhering to post-operative care instructions.

Key Trial Info

Start Date :

August 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 15 2028

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT06536660

Start Date

August 15 2024

End Date

August 15 2028

Last Update

August 5 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.